| RS150814290 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS150815925 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 14 |
| RS150817714 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 2 |
| RS150818164 |
BUB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150819225 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Dyskeratosis congenita |
| RS150819707 |
NODAL
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotaxy, visceral |
| RS150819742 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS150821066 |
ARL13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 8, Inborn genetic diseases |
| RS150821225 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS150821281 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Cardiovascular phenotype |
| RS150822759 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS150822845 |
PLIN1
|
Health Risk |
Likely pathogenic |
PLIN1-related familial partial lipodystrophy, PLIN1-related familial partial lipodystrophy |
| RS150823040 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS150823391 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150825310 |
IFNAR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 45, Immunodeficiency 45 |
| RS150825710 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA |
| RS150825781 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, ALMS1-related disorder |
| RS150828164 |
LIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNA ligase IV deficiency, Multiple myeloma |
| RS150828914 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Inborn genetic diseases |
| RS150829904 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS150830931 |
FECH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150832314 |
ACOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital bile acid synthesis defect 6, ACOX2-related disorder |
| RS150832878 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS150833046 |
GDF5
|
Health Risk |
Conflicting classifications of pathogenicity |
Grebe syndrome, Brachydactyly |
| RS150834054 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS150834671 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS150834672 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
DCHS1-related disorder, DCHS1-related disorder |
| RS150836510 |
MME
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia 43, Spinocerebellar ataxia 43 |
| RS150837465 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS150838488 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS150840308 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Wolfram syndrome 1 |
| RS150840874 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral palsy, spastic quadriplegic |
| RS150840924 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Hutchinson-Gilford syndrome |
| RS150841255 |
GAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities |
| RS150841256 |
SLC34A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS150841275 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS150841323 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150841396 |
PEX3
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 10A (Zellweger), Peroxisome biogenesis disorder 10A (Zellweger) |
| RS150841760 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS150842067 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS150843177 |
TTC19
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 2, Mitochondrial complex III deficiency nuclear type 2 |
| RS150843941 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS150844105 |
TPRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150844949 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS150844967 |
TUFM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150844985 |
SLC38A8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SLC38A8-related disorder |
| RS150844992 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS150846882 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS150847466 |
RASA2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASA2-related disorder, RASA2-related disorder |
| RS150847674 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS150848976 |
OTUD6B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies, seizures |
| RS150849018 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150849326 |
DYM
|
Health Risk |
Conflicting classifications of pathogenicity |
DYM-related disorder, DYM-related disorder |
| RS150850005 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS150850103 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS150851309 |
CD2AP
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 3, susceptibility to |
| RS150851401 |
SLC2A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi-Bickel syndrome, Type 2 diabetes mellitus |
| RS150852085 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS150852382 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS150852779 |
CASP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150854910 |
TF
|
Health Risk |
Conflicting classifications of pathogenicity |
Atransferrinemia, Atransferrinemia |
| RS150854966 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Sotos syndrome |
| RS150855173 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS150855426 |
ATN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150855952 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS150856064 |
RANGRF
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS150857132 |
CRYGD
|
Health Risk |
Conflicting classifications of pathogenicity |
High myopia, Aculeiform cataract |
| RS150857620 |
CLPB
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria, type VIIB |
| RS150858928 |
ETV6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150859301 |
CFAP418
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 16, Retinitis pigmentosa |
| RS150859374 |
NDUFV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS150859573 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150859618 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMC3-related disorder, Inborn genetic diseases |
| RS150860491 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS150860532 |
STRA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS150860808 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
ATP8B1-related disorder, Progressive familial intrahepatic cholestasis type 1 |
| RS150860855 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMA5-related disorder |
| RS150861266 |
GBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS150861658 |
ADAM9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 9, Cone-rod dystrophy 9 |
| RS150861748 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS150862618 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
SAMD9-related disorder, SAMD9-related disorder |
| RS150862707 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS150863050 |
FSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian dysgenesis 1, Ovarian hyperstimulation syndrome |
| RS150863068 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150863093 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Childhood onset GLUT1 deficiency syndrome 2, Childhood onset GLUT1 deficiency syndrome 2 |
| RS150863675 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Inborn genetic diseases |
| RS150864071 |
NEU1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialidosis type 2, Sialidosis type 2 |
| RS150864996 |
SLC39A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary acrodermatitis enteropathica, SLC39A4-related disorder |
| RS150865566 |
FGD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150866176 |
IGF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Silver-Russell syndrome 3 |
| RS150867327 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS150867836 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS150868783 |
TNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 56, TNC-related disorder |
| RS150868941 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS150869428 |
FERMT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 3, Inborn genetic diseases |
| RS150869744 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS150870419 |
CCT5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy with spastic paraplegia, CCT5-related disorder |
| RS150870424 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS150870505 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150870922 |
SLC3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |